Ultragenyx Pharmaceutical, Inc. (RARE)
22.72
+0.89
(+4.08%)
USD |
NASDAQ |
Feb 20, 16:00
22.73
+0.01
(+0.04%)
After-Hours: 20:00
Ultragenyx Pharmaceutical SG&A Expense (Quarterly) : 89.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 123.98M |
| Johnson & Johnson | 6.753B |
| CorMedix, Inc. | 36.64M |
| Insmed, Inc. | 212.48M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |